Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS/MAPK signaling pathway

Yang, F; Jia, M; Deng, CF; Xiao, B; Dai, RY; Xiang, YC

Dai, RY; Xiang, YC (通讯作者),Southwest Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Luzhou, Peoples R China.;Xiang, YC (通讯作者),Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China.

JOURNAL OF MOLECULAR HISTOLOGY, 2022; 53 (4): 729

Abstract

Cisplatin, a first-line chemotherapeutic agent commonly used to treat various solid tumors, induce severe adverse effects, especially nephrotoxicity, ......

Full Text Link